- $3.06bn
- $1.84bn
- $9.18bn
- 59
- 68
- 32
- 52
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.99 | ||
| PEG Ratio (f) | 0.24 | ||
| EPS Growth (f) | 175% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.02 | ||
| Price to Tang. Book | 3.02 | ||
| Price to Free Cashflow | 3.22 | ||
| Price to Sales | 0.33 | ||
| EV to EBITDA | 20.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.18% | ||
| Return on Equity | 2.8% | ||
| Operating Margin | 0.62% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 462.8 | 1,838.71 | 3,963.64 | 5,862.87 | 9,177.56 | 11,175.87 | 11,237.68 | 79.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +661.03 | +37.91 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
Directors
- Jeffery Boyd CHM (64)
- Mario Schlosser CEO (42)
- Joshua Kushner VCH (35)
- R. Scott Blackley CFO (52)
- Meghan Joyce COO (37)
- Ranmali Bopitiya OTH
- Dennis Weaver OTH (60)
- Siddhartha Sankaran DRC (43)
- Joel Cutler IND (63)
- Teri List-Stoll IND (58)
- Charles Phillips IND (61)
- David Plouffe IND (53)
- Elbert Robinson IND (43)
- Vanessa Wittman IND (53)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 25th, 2012
- Public Since
- March 3rd, 2021
- No. of Shareholders
- 27
- No. of Employees
- 2,400
- Sector
- Insurance
- Industry
- Financials
- Exchange
New York Stock Exchange- Shares in Issue
- 250,567,800
- Address
- 75 Varick Street, 5Th Floor, NEW YORK, 10013
- Web
- https://www.hioscar.com/
- Phone
- +1 646403367
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for OSCR
Q1 2025 Oscar Health Inc Earnings Release
Oscar Health Inc Annual Shareholders Meeting
Oscar Health Inc Annual Shareholders Meeting
Q2 2025 Oscar Health Inc Earnings Release
Similar to OSCR
Aegon
New York Stock Exchange
Aflac
New York Stock Exchange
Allstate
New York Stock Exchange
Ambac Financial
New York Stock Exchange
American Financial
New York Stock Exchange
FAQ
What is the Oscar Health share price?
As of Today at 04:29 UTC, shares in Oscar Health are trading at $12.23. This share price information is delayed by 15 minutes.
How has the Oscar Health share price performed this year?
Shares in Oscar Health last closed at $12.23 and the price had moved by -31.64% over the past 365 days. In terms of relative price strength the Oscar Health share price has underperformed the S&P500 Index by -36.9% over the past year.
What are the analyst and broker recommendations for Oscar Health?
The overall consensus recommendation for Oscar Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Oscar Health dividend yield?
Oscar Health does not currently pay a dividend.
Does Oscar Health pay a dividend?
Oscar Health does not currently pay a dividend.
When does Oscar Health next pay dividends?
Oscar Health does not currently pay a dividend.
How do I buy Oscar Health shares?
To buy shares in Oscar Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Oscar Health?
As of the previous close price of $12.23, shares in Oscar Health had a market capitalisation of $3.06bn.
Where are Oscar Health shares listed?
Here are the trading details for Oscar Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: OSCR
What kind of share is Oscar Health?
Based on an overall assessment of its quality, value and momentum Oscar Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Oscar Health share price forecast for 2025?
The analyst consensus target price for shares in Oscar Health is $18.28. That is 49.47% above the last closing price of $12.23.
Analysts covering Oscar Health currently have a consensus Earnings Per Share (EPS) forecast of $0.73 for the next financial year.
Find out moreWhat is the trend in the Oscar Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oscar Health. Over the past six months, its share price has underperformed the S&P500 Index by -20.38%.
As of the last closing price of $12.23, shares in Oscar Health were trading -23.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Oscar Health PE Ratio?
The Oscar Health PE ratio based on its reported earnings over the past 12 months is 14.99. The shares last closed at $12.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Oscar Health?
Oscar Health's management team is headed by:
- Jeffery Boyd - CHM
- Mario Schlosser - CEO
- Joshua Kushner - VCH
- R. Scott Blackley - CFO
- Meghan Joyce - COO
- Ranmali Bopitiya - OTH
- Dennis Weaver - OTH
- Siddhartha Sankaran - DRC
- Joel Cutler - IND
- Teri List-Stoll - IND
- Charles Phillips - IND
- David Plouffe - IND
- Elbert Robinson - IND
- Vanessa Wittman - IND